3 May 2018 - The Australian Government is implementing changes to payment administration arrangements for high cost Pharmaceutical Benefits Scheme listed medicines to ensure continued patient access through community pharmacy and the broader medicines supply chain.

The changes will:

• Increase consumers’ access to high-cost medicines through community pharmacy;
  
• Continue to support a viable community pharmacy network by addressing cash flow concerns raised by pharmacists and wholesalers; and
  
• Address the financial risks associated with the payment of large rebates from medicines companies to Government for some high cost medicines.
  

The changes address issues raised by pharmacists and other stakeholders over recent years and during the independent Review of Pharmacy Remuneration and Regulation.

Read PBS News